Health economic impact and cost threshold for switching from bivalent to nonavalent HPV vaccination for preadolescent girls in KwaZulu Natal, South Africa: A mathematical modeling analysis accounting for the HIV epidemic.

Gardasil 9 (human papillomavirus 9-valent vaccine, recombinant) - Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/42480997

Cari van Schalkwyk; Christine L Hathaway; Darcy W Rao; Jacinda Tran; Louise Kuhn; Monisha Sharma; Ruanne V Barnabas

Jul 22, 2026